Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029328
Filing Date
2019-08-06
Accepted
2019-08-06 16:06:28
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20190630.htm 10-Q 2251517
2 EX-31.1 alrn-ex311_9.htm EX-31.1 16322
3 EX-31.2 alrn-ex312_7.htm EX-31.2 16137
4 EX-32.1 alrn-ex321_8.htm EX-32.1 7921
5 EX-32.2 alrn-ex322_6.htm EX-32.2 6941
  Complete submission text file 0001564590-19-029328.txt   7453933

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20190630.xml EX-101.INS 1611311
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20190630.xsd EX-101.SCH 45207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20190630_cal.xml EX-101.CAL 47153
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20190630_def.xml EX-101.DEF 166148
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20190630_lab.xml EX-101.LAB 400923
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20190630_pre.xml EX-101.PRE 314463
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 191002092
SIC: 2834 Pharmaceutical Preparations